healthcare
healthcare Articles
Aclaris Therapeutics shares sharply dropped early on Thursday after the firm announced results from its midstage trial in alopecia areata.
Published:
Last Updated:
Adaptive Biotechnologies intends to price 15 million shares to reslut in an initial public offering valued up to more than $327 million.
Published:
Last Updated:
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Allergan shares jumped on Tuesday after the company announced that it would be acquired by AbbVie in a cash and stock transaction valued at roughly $63 billion.
Published:
Last Updated:
Akorn shares dipped on Tuesday after the firm announced that it received a warning letter from the FDA related to the inspection of its Somerset, New Jersey, manufacturing facility in July and August...
Published:
Last Updated:
Minerva Neurosciences saw its shares jump on Monday after the firm announced results from a trial related to an insomnia treatment.
Published:
Last Updated:
Ocular Therapeutix shares jumped on Friday after the firm announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Dextenza to include the...
Published:
Last Updated:
Marijuana trends showing higher use after cannabis legalization in Canada.
Published:
Last Updated:
Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for...
Published:
Last Updated:
Health care stocks still have plenty of upside in them. Agilent, Danaher, Thermo Fisher are all stocks to buy.
Published:
Last Updated:
PhaseBio Pharmaceuticals shares jumped on Tuesday after the firm announced preliminary results from its mid-stage trial on subjects on dual antiplatelet therapy of ticagrelor and low-dose aspirin.
Published:
Last Updated:
Baldness is something that many men fear as they age, and understandably so. But Aclaris Therapeutics may have found an answer to it in its most recent mid-stage clinical trial.
Published:
Last Updated:
Array BioPharma shares shot up on Monday after the firm announced that it would be acquired by Pfizer in an all cash transaction. The boards of directors of both companies have approved the merger...
Published:
Last Updated:
Savara shares were absolutely crushed on Thursday after the company released its late-stage results for its treatment of autoimmune pulmonary alveolar proteinosis. Unfortunately, the study did not...
Published:
Last Updated: